Clinical Trials Sponsored by Blaz Barun

Total 192 results

Blaz Barun

Recruiting

Effects of a Mobile App on Adherence to Daily Exercise and Recovery After Whiplash Injury

Whiplash Injury of Cervical Spine

Croatia
Blau Farmaceutica S.A.

Not yet recruiting

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

Anticoagulant
Blaze Bioscience Inc.

Completed

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Central Nervous System Tumors

United States
Blaze Bioscience Inc.

Completed

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Glioma

United States, Australia
Blau Farmaceutica S.A.

Not yet recruiting

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Breast Cancer
Blau Farmaceutica S.A.

Not yet recruiting

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration

Anticoagulant
Blau Farmaceutica S.A.

Not yet recruiting

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Neoplasms | Anemia | Chemotherapeutic-Induced Anemia
Blaze Bioscience Inc.

Available

Expanded Access for BLZ-100 (Tozuleristide)
Blaze Bioscience Inc.

Completed

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Tumors, Breast

United States
K Blal

Terminated

Quantitative Sensory Testing of the Lower Lip After Inferior Alveolar Nerve Block, and Evaluation of the Role of the Contra-lateral Inferior Alveolar Nerve

Healthy
Blaze Bioscience Australia Pty Ltd

Completed

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Skin Neoplasms

Australia
B. Braun Medical LLC

Completed

Study on the Efficacy and Safety of Gelaspan

Hypovolemia

Russian Federation
Azidus Brasil
Blau Farmaceutica S.A.

Completed

Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.

Renal Insufficiency, Chronic

Brazil
Azidus Brasil
Blau Farmaceutica S.A.

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Healthy

Brazil
Azidus Brasil
Blau Farmaceutica S.A.

Terminated

Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.

Anemia | Chronic Kidney Disease

Brazil
B. Braun Medical UK Ltd.

Completed

Acceptability Study on Oral Nutrition Supplement (ONS)

Oral Nutritional Supplementation

United Kingdom
University of Washington
Blaze Bioscience Inc.

Recruiting

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Stage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8

United States
B. Braun Medical SA

Recruiting

PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries (TRELINOIL)

Pressure Ulcer

Spain
B. Braun Medical SA

Not yet recruiting

Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy

Urethral Catheter; Complications
B. Braun Melsungen AG

Recruiting

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Central Venous Catheter

Germany, Italy
B. Braun Medical Inc.

Completed

Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults (3gCefPK)

Infections

United States
B. Braun Melsungen AG

Terminated

Gelatin in ICU and Sepsis (GENIUS)

Hypovolemia

Spain, Austria, Germany, Czechia, France
B. Braun Melsungen AG

Withdrawn

Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon" (ProDect)

Anesthesia, Intravenous | Elective Surgical Procedures
B. Braun Medical SA

Unknown

BE1 Study Spain - CAPSULE SYSTEM FOR COLOSTOMATES (BE1)

Quality of Life of Colostomized Patient
B. Braun Medical Inc.

Completed

(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol (FUTURA)

Hypercholesterolemia

United States
B. Braun Melsungen AG

Completed

Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System

Intensive Care Patients

United Kingdom, Estonia, Denmark, Germany, Poland, Czech Republic, Italy, Spain, Sweden
B. Braun Medical SA

Terminated

ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients (ICULIP)

Critical Illness

Spain
B. Braun Medical Inc.

Withdrawn

Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients

Diabetic Complications

United States
B. Braun Melsungen AG

Completed

Use of a Modified Propofol Emulsion in Adults

Anesthesia

Germany
B. Braun Melsungen AG

Completed

Comparison of HES 130 in Balanced and in Unbalanced Solution

Decreased and Nonspecific Blood Pressure Disorders and Shock

China
B. Braun Melsungen AG

Completed

Usability of Blood Glucose Control With the Space TGC System in Medical ICU Patients (DELIOS 4)

Critical Illness

Switzerland
B. Braun Melsungen AG

Completed

Feasibility of Blood Glucose Control With the Space TGC System in Medical ICU Patients (DELIOS 01)

Critical Illness

Austria
B. Braun Melsungen AG

Completed

Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

Surgery

Germany, Austria, Czech Republic, Italy, Netherlands
B. Braun Medical SA

Recruiting

PMCF Study on the Safety of Linovera Emulsion for the Prevention of Cat-1 Pressure Ulcers, Vascular and DFU (PRELINEM)

Pressure Ulcer

Spain
B. Braun Melsungen AG

Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) (SCORE)

Coronary Artery Disease | Myocardial Ischaemia

Germany
B. Braun Melsungen AG

Completed

The HOME Study (HPN With OMEGA-3) (HOME)

Patients Requiring Home Parenteral Nutrition

Netherlands, United Kingdom, France, Italy, Poland
B. Braun Medical Inc.

Terminated

Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy

Complications Associated With Device

United States
B. Braun Melsungen AG

Completed

Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants

Preterm Infants | Parenteral Nutrition n-3 Fatty Acids

Germany
B. Braun Medical Inc.

Terminated

Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)

Wound of Lower Leg (Physical Finding)

United States
B. Braun Melsungen AG

Completed

Gelatines in Pediatric PatientS (GPS)

Treatment of Hypovolemia and Shock

Spain, Bulgaria, Germany, Italy, United Kingdom
B. Braun Melsungen AG

Completed

Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter (ConSeQuent)

Restenosis | Stenosis

Germany
B. Braun Medical Inc.

Terminated

S.A.F.E.BT System Extracorporeal Treatment With DIAPACT CRRT (SAFEbt)

Severe Sepsis

United States
B. Braun Melsungen AG

Completed

Acceptability Study on Nutricomp® Drink Plus Fibre in Adults (Fuchsia)

Adult Patients in Need of High-energy Oral Nutritional Supplementation

United Kingdom
B. Braun Melsungen AG

Terminated

Different Lipid Emulsions in Acute Lung Injury Patients

Parenteral Nutrition

Germany
B. Braun Melsungen AG

Completed

Efficacy and Safety of a Fish Oil Containing Lipid Emulsion

Parenteral Nutrition

China
B. Braun Melsungen AG

Completed

Feasibility of Tight Blood Glucose Control With the Space TGC System in Surgical ICU Patients (DELIOS 03)

Critical Illness

Germany
B. Braun Medical Inc.

Completed

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy (Secura)

Familial Hypercholesterolemia
B. Braun Melsungen AG

Active, not recruiting

Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

Coronary Artery Disease

France
B. Braun Melsungen AG

Completed

Evaluation of Introcan Safety 3 Closed IV Catheter

Patients in Need for Intravenous Access

Germany
B. Braun Melsungen AG

Active, not recruiting

Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW) (CONSEQUENT)

Peripheral Arterial Occlusive Disease

Germany

3

Subscribe